Repare Therapeutics Inc.
RPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $55,559 | $307,281 | $616,673 | $797,584 |
| - Cash | $84,717 | $111,268 | $159,521 | $334,427 |
| + Debt | $1,933 | $3,410 | $5,428 | $7,313 |
| Enterprise Value | -$27,225 | $199,423 | $462,580 | $470,470 |
| Revenue | $53,477 | $51,133 | $131,830 | $7,600 |
| % Growth | 4.6% | -61.2% | 1,634.6% | – |
| Gross Profit | $40,099 | $37,894 | $15,108 | -$80,254 |
| % Margin | 75% | 74.1% | 11.5% | -1,056% |
| EBITDA | -$90,223 | -$114,273 | -$17,818 | -$107,189 |
| % Margin | -168.7% | -223.5% | -13.5% | -1,410.4% |
| Net Income | -$84,689 | -$93,796 | -$29,047 | -$106,908 |
| % Margin | -158.4% | -183.4% | -22% | -1,406.7% |
| EPS Diluted | -2 | -2.23 | -0.69 | -2.83 |
| % Growth | 10.3% | -223.2% | 75.6% | – |
| Operating Cash Flow | -$76,445 | -$127,158 | $322 | -$85,796 |
| Capital Expenditures | $0 | -$1,938 | -$602 | -$1,690 |
| Free Cash Flow | -$76,445 | -$129,096 | -$280 | -$87,486 |